Delivery Order SPE2DB20D1100-SPE2DB24FD9B5

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD9B5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,119.81 to AmerisourceBergen Drug Corp, Corporate Office Division, for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. This contract has no set-aside designation and has an ultimate completion date of September 19, 2024. AmerisourceBergen is a leading pharmaceutical distributor that provides a wide range of essential medical commodities, including prescription medications, vaccines, and medical supplies, to support various government agencies and healthcare programs. The company holds several Indefinite Delivery Contracts (IDCs) with agencies such as the DLA and the Department of Justice Federal Bureau of Investigation, which serve as primary vehicles for delivering pharmaceutical and medical products to federal customers. This specific delivery order contract is likely part of AmerisourceBergen's broader IDC with the DLA Troop Support Medical, which is valued at up to $999,999,999 through December 2025 and enables the efficient procurement of medical supplies to support military treatment programs and facilities worldwide.

Generated 12/18/24, 9:22 AM